Login / Signup
Alexis Cocozaki
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Dna Damage
Gene Expression
Mouse Model
Immune Response
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Lily L Nguyen
,
Zachary L Watson
,
Raquel Ortega
,
Elizabeth R Woodruff
,
Kimberley R Jordan
,
Ritsuko Iwanaga
,
Tomomi M Yamamoto
,
Courtney A Bailey
,
Francis To
,
Abigail D Jeong
,
Saketh R Guntupalli
,
Kian Behbakht
,
Veronica Gibaja
,
Nausica Arnoult
,
Alexis Cocozaki
,
Edward Boyi Chuong
,
Benjamin G Bitler
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Molecular cancer therapeutics
(2024)
Lily L Nguyen
,
Zachary L Watson
,
Raquel Ortega
,
Elizabeth R Woodruff
,
Kimberley R Jordan
,
Ritsuko Iwanaga
,
Tomomi M Yamamoto
,
Courtney A Bailey
,
Francis To
,
Abigail D Jeong
,
Saketh R Guntupalli
,
Kian Behbakht
,
Veronica Gibaja
,
Nausica Arnoult
,
Alexis Cocozaki
,
Edward Boyi Chuong
,
Benjamin G Bitler
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Molecular cancer therapeutics
(2024)
Lily L Nguyen
,
Zachary L Watson
,
Raquel Ortega
,
Elizabeth R Woodruff
,
Kimberley R Jordan
,
Ritsuko Iwanaga
,
Tomomi M Yamamoto
,
Courtney A Bailey
,
Francis To
,
Abigail D Jeong
,
Saketh R Guntupalli
,
Kian Behbakht
,
Veronica Gibaja
,
Nausica Arnoult
,
Alexis Cocozaki
,
Edward Boyi Chuong
,
Benjamin G Bitler
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Molecular cancer therapeutics
(2024)